Surgery Partners, Inc. — Form 10-Q
Filed August 10, 2026 · analyzed by the Periodic Agent
10-Q
— Neutral
significance 5/100
What the filing says
J. Eric Evans (CEO) and David T. Doherty (CFO) certified Surgery Partners' Q2 2026 10-Q on August 10, 2026. Both officers attest that financial statements fairly present the company's condition, operations, and cash flows; disclosure controls are effective; and no material weaknesses or fraud affecting internal controls were identified. This is standard SOX 302/906 certification.
Why this rating
Routine executive certification required by SEC rules. No new facts, transactions, or control changes disclosed here—purely boilerplate compliance document.
See more from August 10, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.